EssilorLuxottica and Burberry announce licensing partnership renewal EssilorLuxottica and Burberryannounce licensing partnership renewal Paris, France and London, United Kingdom (18 December 2025) – EssilorLuxottica and Burberry today announced the renewal of their licensing agreement for the development, production and global distribution of eyewear under the Burberry brand. The existing agreement, expiring on December 31, 2025, has been extended through December 31, 2035. Building on a shared legacy of creativity, craftsmanship and innovation, the renewal reinforces a long-standing pa...
EssilorLuxottica et Burberry renouvellent leur accord de licence EssilorLuxottica et Burberryrenouvellent leur accord de licence Paris, France et Londres, Royaume-Uni (18 décembre 2025) – EssilorLuxottica et Burberry ont annoncé aujourd’hui le renouvellement de leur accord de licence pour la conception, la production et la distribution mondiale de lunettes sous la marque Burberry. L’accord en vigueur, venant à échéance le 31 décembre 2025, a été prolongé jusqu’au 31 décembre 2035. S'appuyant sur une culture partagée de créativité, de savoir-faire et d'innovation, ce renouvellement vient...
EssilorLuxottica e Burberry rinnovano l’accordo di licenza EssilorLuxottica e Burberry rinnovano l’accordo di licenza Parigi, Francia e Londra, Regno Unito (18 dicembre 2025) – EssilorLuxottica e Burberry annunciano il rinnovo dell’accordo di licenza per lo sviluppo, la produzione e la distribuzione a livello globale di occhiali a marchio Burberry. L’accordo in essere, con scadenza prevista il 31 dicembre 2025, viene rinnovato fino al 31 dicembre 2035. Con una tradizione condivisa di creatività, artigianalità e innovazione, il rinnovo rafforza una collaborazione avviata tra le due socie...
EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint EssilorLuxottica to acquire Signifeye,further growing its ophthalmology clinics footprint Paris, France (12 December 2025) – EssilorLuxottica announced today the acquisition of Signifeye, a leading Belgian ophthalmology platform delivering top-tier patient care across 15 eye centers and clinics in the Flanders region. The transaction comes soon after the recent acquisition of Optegra, a fast-growing and highly integrated ophthalmology platform in Europe operating over 70 clinics in the UK, Czech Re...
EssilorLuxottica va acquérir Signifeye, poursuivant l’extension de son réseau de cliniques ophtalmologiques EssilorLuxottica va acquérir Signifeye,poursuivant l’extension de son réseau de cliniques ophtalmologiques Paris, France (12 décembre 2025) – EssilorLuxottica a annoncé aujourd’hui l’acquisition de Signifeye, une plateforme d’ophtalmologie belge de premier plan qui propose aux patients des prestations médicales de haut niveau grâce à 15 cliniques et centres de l’œil situés en Flandre. Cette transaction fait suite à la récente acquisition d’Optegra, une plateforme européenne d'ophta...
EssilorLuxottica acquisisce Signifeye e continua ad espandere la sua rete di cliniche oftalmiche EssilorLuxottica acquisisce Signifeyee continua ad espandere la sua rete di cliniche oftalmiche Parigi, Francia (12 dicembre 2025) – EssilorLuxottica annuncia l’acquisizione di Signifeye, una delle principali piattaforme oftalmiche belghe che offre percorsi di cura di eccellenza attraverso 15 cliniche oftalmiche e centri diagnostici nella regione delle Fiandre. L’operazione fa seguito alla recente acquisizione di Optegra, una piattaforma oftalmica europea in forte espansione e perfettamente...
EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear EssilorLuxottica joins forces with Fondazione Chips-ITto accelerate the future of smart eyewear Paris, France (10 December 2025) – EssilorLuxottica announces it is joining forces with Fondazione Chips-IT, Italy’s research center specializing in advanced integrated-circuit design, during today’s presentation of the foundation’s 2026-2028 strategic plan. This collaboration aims to further strengthen the Group’s leadership in smart eyewear by advancing application-specific chip development within...
EssilorLuxottica va collaborer avec la fondation Chips-IT pour accélérer dans les lunettes connectées EssilorLuxottica va collaborer avec la fondation Chips-IT pour accélérer dans les lunettes connectées Paris, France (10 décembre 2025) – EssilorLuxottica a annoncé aujourd'hui une collaboration avec la fondation Chips-IT, un centre italien de recherche spécialisé dans la conception avancée de circuits intégrés, à l’occasion de la présentation du plan stratégique 2026-2028 de la fondation. Cette collaboration vise à renforcer la position d'EssilorLuxottica dans les lunettes connectées en fa...
EssilorLuxottica annuncia l’avvio di una collaborazione con Fondazione Chips-IT e accelera sugli smart glasses del futuro EssilorLuxottica annuncia l’avvio di una collaborazione con Fondazione Chips-IT e accelera sugli smart glasses del futuro Parigi, Francia (10 dicembre 2025) – EssilorLuxottica ha annunciato l’avvio di una collaborazione con Fondazione Chips-IT, centro di ricerca italiano specializzato nella progettazione avanzata di circuiti integrati, in occasione della presentazione del piano strategico 2026-2028 della fondazione. La partnership rafforza ulteriormente la leadership ...
A director at Pernod-Ricard bought 525 shares at 75.800EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.